Casi Pharmaceuticals Acquires Global Intellectual Property Rights To Cleave Therapeutics' Vcp/P97 Inhibitor Cb-5339
Acquiring Company
CASI Pharmaceuticals
Description
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the execution of the Assignment Agreement (the "Agreement") with Cleave Therapeutics, Inc. ("Cleave"), pursuant to which CASI obtained all rights and global intellectual property rights related to CB-5339, a novel VCP/p97 inhibitor, as well as all remaining CB-5339 drug substance and drug product. Additionally, CASI will assume responsibility of the United States ("US") CB-5339 Investigational New Drug ("IND") application.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cybin To Acquire Small Pharma Inc. (August 28, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Lilly Completes Acquisition Of Dice Therapeutics (August 9, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Lilly Completes Acquisition Of Sigilon Therapeutics (August 14, 2023)
Who to call at CASI Pharmaceuticals, and when
When CASI Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CASI Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CASI Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CASI Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CASI Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.